Centric Health Corporation provides pharmacy and other healthcare services to patients and customers in Canada.
+ 1 more risk
Worrying balance sheet with weak fundamentals.
Share Price & News
How has Centric Health's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 29C's share price has been volatile over the past 3 months.
7 Day Return
DE Consumer Retailing
1 Year Return
DE Consumer Retailing
Return vs Industry: 29C underperformed the German Consumer Retailing industry which returned 1.8% over the past year.
Return vs Market: 29C underperformed the German Market which returned 14.1% over the past year.
Price Volatility Vs. Market
How volatile is Centric Health's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is Centric Health undervalued compared to its fair value and its price relative to the market?
In this section, we usually try to help investors determine whether Centric Health is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Centric Health has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.
This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.
- Take a look at our analysis of 29C’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
- When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Centric Health regulatory filings.
- Explore potentially undervalued companies in the Consumer Retailing industry.
How is Centric Health forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
Forecasted annual revenue growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 29C's forecast earnings growth is above the savings rate (-0.4%).
Earnings vs Market: Insufficient data to determine if 29C's earnings are forecast to grow faster than the German market
High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 29C's revenue (4.4% per year) is forecast to grow slower than the German market (5% per year).
High Growth Revenue: 29C's revenue (4.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 29C's Return on Equity is forecast to be high in 3 years time
How has Centric Health performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 29C is currently unprofitable.
Growing Profit Margin: 29C is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: 29C is unprofitable, but has reduced losses over the past 5 years at a rate of 22% per year.
Accelerating Growth: Unable to compare 29C's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 29C is unprofitable, making it difficult to compare its past year earnings growth to the Consumer Retailing industry (-0.7%).
Return on Equity
High ROE: 29C's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.
Return on Assets
Return on Capital Employed
How is Centric Health's financial position?
Financial Position Analysis
Short Term Liabilities: 29C has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: 29C has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: 29C has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: 29C's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Inventory Level: 29C has a low level of unsold assets or inventory.
Debt Coverage by Assets: 29C has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 29C has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 29C has less than a year of cash runway if free cash flow continues to reduce at historical rates of -25.8% each year
What is Centric Health's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate 29C's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate 29C's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 29C's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 29C's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 29C's dividend in 3 years as they are not forecast to pay a notable one for the German market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
David Murphy 0
Mr. David Murphy has been the President at Cardinal Health Canada Inc. since April 2016. He has been the President and Chief Executive Officer at Centric Health Corporation since May 1, 2018. He has been a ...
CEO Compensation Analysis
Compensation vs Market: David's total compensation ($USD488.30K) is about average for companies of similar size in the German market ($USD413.42K).
Compensation vs Earnings: Insufficient data to compare David's compensation with company performance.
|Chief Financial Officer||1.3yrs||CA$198.66k||0.043% CA$13.5k|
|VP, General Counsel & Corporate Secretary||2.4yrs||CA$281.20k||0.017% CA$5.4k|
|VP & GM of Western Canada for the Specialty Pharmacy Division||3.1yrs||CA$234.67k||no data|
|Chief Human Resources Officer||1.3yrs||no data||no data|
|Head of Catastrophic Injury Assessment Field||13.8yrs||no data||no data|
Experienced Management: 29C's management team is considered experienced (2.1 years average tenure).
|Independent Member of the Board of Directors||0.6yrs||no data||0.034% CA$10.8k|
|Chairman Emeritus||1.7yrs||CA$279.08k||5.96% CA$1.9m|
|Independent Non-Executive Director||7yrs||CA$93.43k||0.059% CA$18.6k|
|Independent Director||0.9yrs||no data||no data|
|Independent Chairman of the Board||1.7yrs||CA$120.44k||0.047% CA$14.9k|
|Director||0.3yrs||no data||no data|
|Director||0.3yrs||no data||no data|
Experienced Board: 29C's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.7%.
Centric Health Corporation's company bio, employee growth, exchange listings and data sources
- Name: Centric Health Corporation
- Ticker: 29C
- Exchange: DB
- Founded: 2001
- Industry: Drug Retail
- Sector: Consumer Retailing
- Market Cap: CA$45.279m
- Listing Market Cap: CA$31.566m
- Shares outstanding: 292.12m
- Website: https://www.centrichealth.ca
Number of Employees
- Centric Health Corporation
- 20 Eglinton Avenue West
- Suite 2100
- M4R 1K8
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|CHH||TSX (The Toronto Stock Exchange)||Yes||Common Shares||CA||CAD||Jun 2003|
|CHHH.F||OTCPK (Pink Sheets LLC)||Yes||Common Shares||US||USD||Jun 2003|
|29C||DB (Deutsche Boerse AG)||Yes||Common Shares||DE||EUR||Jun 2003|
Centric Health Corporation provides pharmacy and other healthcare services to patients and customers in Canada. The company operates a network of pharmacy fulfilment centers that provide chronic medication and other specialty clinical pharmacy services for long term care and retirement communities, and assisted living facilities. It serves approximately 30,000 residents in 450 senior communities through a network of 15 fulfilment centers. The company was formerly known as Alegro Health Corp. and changed its name to Centric Health Corporation in August 2009. Centric Health Corporation was incorporated in 2001 and is headquartered in Toronto, Canada.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/02/19 22:33|
|End of Day Share Price||2020/02/19 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.